(Q70833463)
Statements
No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation (English)
Hägglund H
Ringdén O
Winiarski J
Ericzon B
1 December 1995